Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health
Bill to allow imported drugs from Canada aims to create competition
Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That’s about to change.
Five things for pharma marketers to know: Tuesday, August 8, 2017
Drugmakers inconsistently share clinical trial data; AstraZeneca’s share price falls after Mystic results; some pregnancy apps share info with marketers
Gilead’s educational campaign boosted HCV diagnosis rates for baby boomers
An unbranded campaign encouraging baby boomers to get tested for hepatitis C helped boost screening and diagnosis numbers, which in turn upped sales of its HCV therapies.
Five things for pharma marketers to know: Wednesday, July 26, 2017